(Press-News.org) Scientists at Queen's University Belfast have led the discovery of a volcanic ash cloud that travelled from Alaska to Northern Ireland and beyond - overturning previously held assumptions about how far ash deposits can drift, with major implications for the airline industry.
The discovery, which was made in partnership with an international team of academics and has been published in the journal Geology, is the first evidence that ash clouds can travel across the Atlantic Ocean, confirming Queen's as a global leader in research. This particular ash, found in sites across Europe, including Sluggan Bog near Randalstown, Co Antrim, has been traced to an eruption from Mount Bona-Churchill in Alaska, around AD 847.
The discovery has significant implications for the aviation industry as well as environmental science, illustrating Queen's impact on a global scale. The plumes spewed out by the volcano Eyjafjallajokull, in Iceland in 2010, caused major disruption and grounded over 100,000 international flights, costing airlines more than £2 billion.
With volcanoes like Mount Bona-Churchill - much more volatile than Eyjafjallajokull - scheduled to erupt on average every 100 years, another ash-cloud drama could be imminent, this time with consequences for trans-Atlantic as well as European travel.
Lead researcher Dr Britta Jensen from Queen's School of Geography, Archaeology and Paleoecology (GAP) said: "The ash, or tephra, is from Mount Bona-Churchill where it is called the White River Ash and occurs as a thick white layer spreading eastwards into Canada. Using chemical 'fingerprinting', the team has matched it to a tephra layer which occurs in Ireland, Norway, Germany and Greenland, where it is called the AD860B. For the past 20 years or so, European researchers assumed that AD860B came from a relatively nearby volcano in Iceland, which is the source of most ash in Europe, including that from Eyjafjallajokull in 2010. However, the AD860B never quite fitted with what researchers knew of volcanoes in Iceland."
Co-researcher Dr Sean Pyne-O'Donnell from Queen's School of GAP said the discovery was also significant in advancing knowledge across other disciplines, particularly in the area of climate change: "The layer was deposited very quickly after eruption, probably within a matter of days and can be used to precisely date and compare the relative timing of any environmental or archaeological events associated with it by tephro-chronology. This makes the layer very useful for researchers wanting to link together how climate behaved in distant parts of the world at this time. Such information is vital for climate scientists attempting to explain how climate worked in the past compared with the present. The team also speculates that other tephra layers from similar trans-Atlantic eruptions may yet be uncovered in other Irish sites."
INFORMATION:
To read the full paper, click here: http://geology.gsapubs.org/content/42/10/875.full.pdf
For further information, contact the Queen's University Communications Officers Una Bradley on +0044 (0)28 9097 5320 (Mon-Wed) or Michelle Cassidy on +0044 (0)28 9097 5310 (Thurs-Fri) or email comms.officer@qub.ac.uk
Notes To Editors:
1. Dr Sean Pyne-O'Donnell is available for interview. Media bids to the the Queen's University Communications Office on +0044 (0)28 9097 5320 (Mon-Wed) or +0044 (0)28 9097 5310 (Thurs-Fri) or email comms.officer@qub.ac.uk
2. The full research team comprises:
Britta J.L. Jensen1,2, Sean Pyne-O'Donnell2,3, Gill Plunkett2, Duane G. Froese1, Paul D.M. Hughes4, Michael Sigl5, Joseph R. McConnell5, Matthew J. Amesbury6, Paul G. Blackwell7, Christel van den Bogaard8, Caitlin E. Buck7, Dan J. Charman6, John J. Clague9, Valerie A. Hall2, Johannes Koch9,10, Helen Mackay4, Gunnar Mallon11, Lynsey McColl12, and Jonathan R. Pilcher2
1Department of Earth and Atmospheric Sciences, University of Alberta, Edmonton, Alberta T6G 2E3, Canada
2School of Geography, Archaeology, and Palaeoecology, Queen's University Belfast, Belfast BT7 1NN, UK
3Department of Earth Science, University of Bergen, Allégaten 41, Bergen N-5007, Norway
4Palaeoenvironmental Laboratory (PLUS), Geography and Environment, University of Southampton, Southampton SO17 1BJ, UK
5Desert Research Institute, 2215 Raggio Parkway, Reno, Nevada 89512, USA
6Department of Geography, College of Life and Environmental Sciences, University of Exeter, Exeter EX4 4RJ, UK
7School of Mathematics and Statistics, University of Sheffield, Sheffield S10 2TN, UK
8GEOMAR Helmholtz Centre for Ocean Research Kiel, Wischhofstrasse 1-3, Kiel D-24148, Germany
9Department of Earth Sciences, Simon Fraser University, Burnaby, British Columbia V5A 1S6, Canada
10Department of Geography, Brandon University, Brandon, Manitoba R7A 6A9, Canada
11Department of Geography, University of Sheffield, Sheffield S10 2TN, UK
12Select Statistics, Exeter Business Park, Exeter, Devon EX1 3LH, UK
Barcelona, Spain: Researchers have found a way of identifying which ovarian cancer patients are likely to respond well to a new anti-cancer drug called rucaparib.
Results of clinical trials have shown that women with tumours that are sensitive to platinum-based chemotherapy and who carry inherited mutations in the BRCA1/2 genes respond well to rucaparib. But in new findings presented today (Thursday) at the 26th EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics in Barcelona, Spain, researchers say that they have identified a biological indicator ...
Barcelona, Spain: A drug that is already well established as a treatment for infection of the retina in people with AIDS has been shown, for the first time, to sensitise cervical cancer to chemotherapy and radiotherapy without an increase in toxic side-effects.
Cidofovir is an anti-viral drug that is effective against several viruses, including the human papilloma virus (HPV), which is implicated in the onset of cervical cancer. It targets the cancer-causing proteins (oncoproteins) produced by HPV. These oncoproteins interfere with the action of other proteins that control ...
Barcelona, Spain: Patients with B-cell Non-Hodgkin lymphomas and advanced solid tumours have responded to a new drug that is being tested for the first time in humans in a phase I clinical trial.
Preliminary results from the trial will be presented today (Thursday) at the 26th EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics in Barcelona, Spain. They show responses in four lymphoma patients who have failed numerous previous treatments and also in one patient with a cancer for which there is no approved medical treatment at all - a malignant rhabdoid ...
EAST LANSING, Mich. --- Older couples in a bad marriage -- particularly female spouses -- have a higher risk for heart disease than those in a good marriage, finds the first nationally representative study of its kind.
The findings suggest the need for marriage counseling and programs aimed at promoting marital quality and well-being for couples into their 70s and 80s, said lead investigator Hui Liu, a Michigan State University sociologist.
"Marriage counseling is focused largely on younger couples," said Liu, associate professor of sociology. "But these results show ...
WASHINGTON, D.C. - Scientists have created video games that add an important element of fun to the repetitive training needed to improve vision in people - including adults - with a lazy eye and poor depth perception.
The training tools, including a Pac-Man-style "cat and mouse" game and a "search for oddball" game, have produced results in pilot testing: Weak-eye vision improved to 20/20 and 20/50 in two adult research participants with lazy eyes whose vision was 20/25 and 20/63, respectively, before the training began.
Unlike the common use of eye patches on dominant ...
LOUISVILLE, Ky. - One year ago, Michael Stillman, M.D., and his colleague, Monalisa Tailor, M.D., both physicians with the University of Louisville Department of Medicine, wrote a New England Journal of Medicine "Perspective" article about "Tommy Davis," their pseudonym-named patient who delayed seeing a doctor because he lacked health insurance.
After spending a year experiencing severe abdominal pain and other symptoms, Davis finally sought care in the emergency room. The diagnosis? Metastatic colon cancer.
"If we'd found it sooner," Davis said to the physicians, ...
November 19, 2014, New York, NY - A team led by Ludwig and Memorial Sloan Kettering (MSK) researchers has published a landmark study on the genetic basis of response to a powerful cancer therapy known as immune checkpoint blockade. Their paper, in the current issue of the New England Journal of Medicine, describes the precise genetic signatures in melanoma tumors that determine whether a patient will respond to one such therapy. It also explains in exquisite detail how those genetic profiles translate into subtle molecular changes that enable the immune system attack of ...
A new self-contained leadless cardiac pacemaker is a safe and reliable alternative to conventional pacemakers, according to research presented at the American Heart Association's Scientific Sessions 2014.
The new device reduces complications that have existed over the last 50 years that are associated with lead placement and performance and the pulse generator situated under the skin that have occurred with conventional pacemaker systems.
In the first trial of the leadless pacemaker, doctors implanted one in eight patients (average 82 years old, 75 percent men) with ...
More children with dilated cardiomyopathy are surviving without a heart transplant, according to research presented at the American Heart Association's Scientific Sessions 2014.
Dilated cardiomyopathy occurs when the heart is enlarged (dilated) and the pumping chambers contract poorly (usually left side is worse than right). It can have genetic and infectious/environmental causes.
Researchers analyzed the clinical outcomes of children with dilated cardiomyopathy in the NHLBI Pediatric Cardiomyopathy Registry (PCMR) and divided them into two groups based upon year of ...
Children whose parents spend a lot of time sitting in front of a computer or other screen are more likely than other children to have excessive screen-time habits, as well as associated risks for heart and blood vessel disease, according to a study presented at the American Heart Association's Scientific Sessions 2014.
"Screen time of children is significantly associated with parental screen time," said Masao Yoshinaga, M.D., Ph.D., the study's lead author and chief director of pediatrics at National Hospital Organization, Kagoshima Medical Center in Japan. "To reduce ...
